ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tafenoquine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-26W8342
Home | Market Reports | Health| Pharmacy
Global Tafenoquine Market Insights Forecast to 2028
BUY CHAPTERS

Global Tafenoquine Market Research Report 2025

Code: QYRE-Auto-26W8342
Report
July 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline Pharmaceuticals (GSK)
J& K Scientific Ltd
Boc Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck

Tafenoquine Market

The global market for Tafenoquine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Tafenoquine is an aminoquinoline that is used in combination with other antimalarials for the prevention of relapse of Plasmodium vivax malaria and by itself as prophylaxis against all species of malaria. Tafenoquine has been linked to low rates of transient and asymptomatic serum enzyme elevations during therapy but has not been associated with instances of clinically apparent acute liver injury.
North American market for Tafenoquine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tafenoquine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tafenoquine include GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited, Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tafenoquine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tafenoquine.
The Tafenoquine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tafenoquine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tafenoquine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tafenoquine Market Report

Report Metric Details
Report Name Tafenoquine Market
Segment by Type
  • Powder
  • Pills
Segment by Application
  • Radical Cure of P.vivax
  • P. falciparum Treatment
  • Prevention of Malaria Relapse
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited, Merck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tafenoquine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tafenoquine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Tafenoquine Market report?

Ans: The main players in the Tafenoquine Market are GlaxoSmithKline Pharmaceuticals (GSK), J & K Scientific LTD, BOC Sciences, WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd., Pharmacodia (Beijing) Co.,Ltd, Amadis Chemical Company Limited, Merck

What are the Application segmentation covered in the Tafenoquine Market report?

Ans: The Applications covered in the Tafenoquine Market report are Radical Cure of P.vivax, P. falciparum Treatment, Prevention of Malaria Relapse

What are the Type segmentation covered in the Tafenoquine Market report?

Ans: The Types covered in the Tafenoquine Market report are Powder, Pills

1 Tafenoquine Market Overview
1.1 Product Definition
1.2 Tafenoquine by Type
1.2.1 Global Tafenoquine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Powder
1.2.3 Pills
1.3 Tafenoquine by Application
1.3.1 Global Tafenoquine Market Value by Application (2024 VS 2031)
1.3.2 Radical Cure of P.vivax
1.3.3 P. falciparum Treatment
1.3.4 Prevention of Malaria Relapse
1.4 Global Tafenoquine Market Size Estimates and Forecasts
1.4.1 Global Tafenoquine Revenue 2020-2031
1.4.2 Global Tafenoquine Sales 2020-2031
1.4.3 Global Tafenoquine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tafenoquine Market Competition by Manufacturers
2.1 Global Tafenoquine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tafenoquine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tafenoquine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tafenoquine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tafenoquine, Product Type & Application
2.7 Global Key Manufacturers of Tafenoquine, Date of Enter into This Industry
2.8 Global Tafenoquine Market Competitive Situation and Trends
2.8.1 Global Tafenoquine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tafenoquine Players Market Share by Revenue
2.8.3 Global Tafenoquine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tafenoquine Market Scenario by Region
3.1 Global Tafenoquine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tafenoquine Sales by Region: 2020-2031
3.2.1 Global Tafenoquine Sales by Region: 2020-2025
3.2.2 Global Tafenoquine Sales by Region: 2026-2031
3.3 Global Tafenoquine Revenue by Region: 2020-2031
3.3.1 Global Tafenoquine Revenue by Region: 2020-2025
3.3.2 Global Tafenoquine Revenue by Region: 2026-2031
3.4 North America Tafenoquine Market Facts & Figures by Country
3.4.1 North America Tafenoquine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tafenoquine Sales by Country (2020-2031)
3.4.3 North America Tafenoquine Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Tafenoquine Market Facts & Figures by Country
3.5.1 Europe Tafenoquine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tafenoquine Sales by Country (2020-2031)
3.5.3 Europe Tafenoquine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tafenoquine Market Facts & Figures by Region
3.6.1 Asia Pacific Tafenoquine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tafenoquine Sales by Region (2020-2031)
3.6.3 Asia Pacific Tafenoquine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Tafenoquine Market Facts & Figures by Country
3.7.1 Latin America Tafenoquine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tafenoquine Sales by Country (2020-2031)
3.7.3 Latin America Tafenoquine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tafenoquine Market Facts & Figures by Country
3.8.1 Middle East and Africa Tafenoquine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tafenoquine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tafenoquine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tafenoquine Sales by Type (2020-2031)
4.1.1 Global Tafenoquine Sales by Type (2020-2025)
4.1.2 Global Tafenoquine Sales by Type (2026-2031)
4.1.3 Global Tafenoquine Sales Market Share by Type (2020-2031)
4.2 Global Tafenoquine Revenue by Type (2020-2031)
4.2.1 Global Tafenoquine Revenue by Type (2020-2025)
4.2.2 Global Tafenoquine Revenue by Type (2026-2031)
4.2.3 Global Tafenoquine Revenue Market Share by Type (2020-2031)
4.3 Global Tafenoquine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tafenoquine Sales by Application (2020-2031)
5.1.1 Global Tafenoquine Sales by Application (2020-2025)
5.1.2 Global Tafenoquine Sales by Application (2026-2031)
5.1.3 Global Tafenoquine Sales Market Share by Application (2020-2031)
5.2 Global Tafenoquine Revenue by Application (2020-2031)
5.2.1 Global Tafenoquine Revenue by Application (2020-2025)
5.2.2 Global Tafenoquine Revenue by Application (2026-2031)
5.2.3 Global Tafenoquine Revenue Market Share by Application (2020-2031)
5.3 Global Tafenoquine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline Pharmaceuticals (GSK)
6.1.1 GlaxoSmithKline Pharmaceuticals (GSK) Company Information
6.1.2 GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
6.1.3 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product Portfolio
6.1.5 GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
6.2 J & K Scientific LTD
6.2.1 J & K Scientific LTD Company Information
6.2.2 J & K Scientific LTD Description and Business Overview
6.2.3 J & K Scientific LTD Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 J & K Scientific LTD Tafenoquine Product Portfolio
6.2.5 J & K Scientific LTD Recent Developments/Updates
6.3 BOC Sciences
6.3.1 BOC Sciences Company Information
6.3.2 BOC Sciences Description and Business Overview
6.3.3 BOC Sciences Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BOC Sciences Tafenoquine Product Portfolio
6.3.5 BOC Sciences Recent Developments/Updates
6.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
6.4.1 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
6.4.2 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
6.4.3 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product Portfolio
6.4.5 WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
6.5 Pharmacodia (Beijing) Co.,Ltd
6.5.1 Pharmacodia (Beijing) Co.,Ltd Company Information
6.5.2 Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
6.5.3 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product Portfolio
6.5.5 Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
6.6 Amadis Chemical Company Limited
6.6.1 Amadis Chemical Company Limited Company Information
6.6.2 Amadis Chemical Company Limited Description and Business Overview
6.6.3 Amadis Chemical Company Limited Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amadis Chemical Company Limited Tafenoquine Product Portfolio
6.6.5 Amadis Chemical Company Limited Recent Developments/Updates
6.7 Merck
6.7.1 Merck Company Information
6.7.2 Merck Description and Business Overview
6.7.3 Merck Tafenoquine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck Tafenoquine Product Portfolio
6.7.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tafenoquine Industry Chain Analysis
7.2 Tafenoquine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tafenoquine Production Mode & Process Analysis
7.4 Tafenoquine Sales and Marketing
7.4.1 Tafenoquine Sales Channels
7.4.2 Tafenoquine Distributors
7.5 Tafenoquine Customer Analysis
8 Tafenoquine Market Dynamics
8.1 Tafenoquine Industry Trends
8.2 Tafenoquine Market Drivers
8.3 Tafenoquine Market Challenges
8.4 Tafenoquine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline Pharmaceuticals (GSK)
J& K Scientific Ltd
Boc Sciences
WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.
Pharmacodia (Beijing) Co.,Ltd
Amadis Chemical Company Limited
Merck
List of Tables
 Table 1. Global Tafenoquine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tafenoquine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tafenoquine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tafenoquine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tafenoquine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tafenoquine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tafenoquine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tafenoquine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tafenoquine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tafenoquine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tafenoquine, Product Type & Application
 Table 12. Global Key Manufacturers of Tafenoquine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tafenoquine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tafenoquine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tafenoquine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tafenoquine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tafenoquine Sales Market Share by Region (2020-2025)
 Table 19. Global Tafenoquine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tafenoquine Sales Market Share by Region (2026-2031)
 Table 21. Global Tafenoquine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tafenoquine Revenue Market Share by Region (2020-2025)
 Table 23. Global Tafenoquine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tafenoquine Revenue Market Share by Region (2026-2031)
 Table 25. North America Tafenoquine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tafenoquine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tafenoquine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tafenoquine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tafenoquine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tafenoquine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tafenoquine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tafenoquine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tafenoquine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tafenoquine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tafenoquine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tafenoquine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tafenoquine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tafenoquine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tafenoquine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tafenoquine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tafenoquine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tafenoquine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tafenoquine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tafenoquine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tafenoquine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tafenoquine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tafenoquine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tafenoquine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tafenoquine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tafenoquine Sales (K Units) by Type (2020-2025)
 Table 51. Global Tafenoquine Sales (K Units) by Type (2026-2031)
 Table 52. Global Tafenoquine Sales Market Share by Type (2020-2025)
 Table 53. Global Tafenoquine Sales Market Share by Type (2026-2031)
 Table 54. Global Tafenoquine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tafenoquine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tafenoquine Revenue Market Share by Type (2020-2025)
 Table 57. Global Tafenoquine Revenue Market Share by Type (2026-2031)
 Table 58. Global Tafenoquine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tafenoquine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tafenoquine Sales (K Units) by Application (2020-2025)
 Table 61. Global Tafenoquine Sales (K Units) by Application (2026-2031)
 Table 62. Global Tafenoquine Sales Market Share by Application (2020-2025)
 Table 63. Global Tafenoquine Sales Market Share by Application (2026-2031)
 Table 64. Global Tafenoquine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tafenoquine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tafenoquine Revenue Market Share by Application (2020-2025)
 Table 67. Global Tafenoquine Revenue Market Share by Application (2026-2031)
 Table 68. Global Tafenoquine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tafenoquine Price (US$/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Pharmaceuticals (GSK) Company Information
 Table 71. GlaxoSmithKline Pharmaceuticals (GSK) Description and Business Overview
 Table 72. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Pharmaceuticals (GSK) Tafenoquine Product
 Table 74. GlaxoSmithKline Pharmaceuticals (GSK) Recent Developments/Updates
 Table 75. J & K Scientific LTD Company Information
 Table 76. J & K Scientific LTD Description and Business Overview
 Table 77. J & K Scientific LTD Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. J & K Scientific LTD Tafenoquine Product
 Table 79. J & K Scientific LTD Recent Developments/Updates
 Table 80. BOC Sciences Company Information
 Table 81. BOC Sciences Description and Business Overview
 Table 82. BOC Sciences Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BOC Sciences Tafenoquine Product
 Table 84. BOC Sciences Recent Developments/Updates
 Table 85. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Company Information
 Table 86. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Description and Business Overview
 Table 87. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Tafenoquine Product
 Table 89. WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd. Recent Developments/Updates
 Table 90. Pharmacodia (Beijing) Co.,Ltd Company Information
 Table 91. Pharmacodia (Beijing) Co.,Ltd Description and Business Overview
 Table 92. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pharmacodia (Beijing) Co.,Ltd Tafenoquine Product
 Table 94. Pharmacodia (Beijing) Co.,Ltd Recent Developments/Updates
 Table 95. Amadis Chemical Company Limited Company Information
 Table 96. Amadis Chemical Company Limited Description and Business Overview
 Table 97. Amadis Chemical Company Limited Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Amadis Chemical Company Limited Tafenoquine Product
 Table 99. Amadis Chemical Company Limited Recent Developments/Updates
 Table 100. Merck Company Information
 Table 101. Merck Description and Business Overview
 Table 102. Merck Tafenoquine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck Tafenoquine Product
 Table 104. Merck Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Tafenoquine Distributors List
 Table 108. Tafenoquine Customers List
 Table 109. Tafenoquine Market Trends
 Table 110. Tafenoquine Market Drivers
 Table 111. Tafenoquine Market Challenges
 Table 112. Tafenoquine Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tafenoquine
 Figure 2. Global Tafenoquine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tafenoquine Market Share by Type: 2024 & 2031
 Figure 4. Powder Product Picture
 Figure 5. Pills Product Picture
 Figure 6. Global Tafenoquine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tafenoquine Market Share by Application: 2024 & 2031
 Figure 8. Radical Cure of P.vivax
 Figure 9. P. falciparum Treatment
 Figure 10. Prevention of Malaria Relapse
 Figure 11. Global Tafenoquine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Tafenoquine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Tafenoquine Sales (2020-2031) & (K Units)
 Figure 14. Global Tafenoquine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Tafenoquine Report Years Considered
 Figure 16. Tafenoquine Sales Share by Manufacturers in 2024
 Figure 17. Global Tafenoquine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Tafenoquine Players: Market Share by Revenue in Tafenoquine in 2024
 Figure 19. Tafenoquine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Tafenoquine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Tafenoquine Sales Market Share by Country (2020-2031)
 Figure 22. North America Tafenoquine Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Tafenoquine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Tafenoquine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Tafenoquine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Tafenoquine Revenue Market Share by Region (2020-2031)
 Figure 34. China Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Tafenoquine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Tafenoquine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Tafenoquine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Tafenoquine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Tafenoquine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Tafenoquine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Tafenoquine by Type (2020-2031)
 Figure 56. Global Tafenoquine Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Tafenoquine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Tafenoquine by Application (2020-2031)
 Figure 59. Global Tafenoquine Price (US$/Unit) by Application (2020-2031)
 Figure 60. Tafenoquine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Hydroxychloroquine Market Research Report 2024
Atovaquone and Proguanil Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chloroquine Products Market Research Report 2024
Global Artemether Lumefantrine Tablets Market Research Report 2024
Global Artemisinin Combination Therapy Market Insights Forecast to 2030
Global Mefloquine Market Research Report 2025
Global Hydroxychloroquine Plaquenil Market Research Report 2024
Global Primaquine Phosphate Tablets Market Research Report 2024
Global Compound Artemether Tablets Market Research Report 2024
Global Sulfadoxine Market Insights Forecast to 2030
Global Pirfenidone Drugs Market Research Report 2024
Global Tenofovir Alafenamide and Its Combination Drugs Market Research Report 2024
Global Chloroquine Phosphate Market Insights Forecast to 2030
Global Rafoxanide Market Research Report 2024
Global Artesunate Market Research Report 2024
Flecainide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Propafenone Market Research Report 2024
Global Chloroquine Market Research Report 2025
Global Artesunate Tablet Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Artesunate Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions